Celine Koh

Cooley advised AIM Intelligent Machines, the world’s first embodied artificial intelligence platform for earthmoving machinery, on its $50 million fundraise from various investors, including Khosla Ventures and General Catalyst. AIM will use the funding to transform the global construction and mining industries. Partner Sale Kwon led the Cooley team advising AIM.

Cooley represented Wheeler Bio in the closing of its $35 million Series A-1 financing round. This funding will support Wheeler Bio’s ongoing efforts to expand its capabilities and accelerate the advancement of its partners’ therapies. Lawyers Sale Kwon and Emily Lee led the Cooley team advising Wheeler Bio, a developer of biomanufacturing services designed to translate therapeutic innovations into clinical impact.

Cooley advised Baseten, the top inference platform for artificial intelligence (AI)-native products, on its $75 million Series C financing, bringing its total funding to $135 million.

Cooley advised Delphix, a vendor of test data management software, on its acquisition by Perforce, a provider of solutions to enterprise teams requiring productivity, visibility and scale along the development life cycle.

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.